Liontown Ltd shares (ASX: LTR) has suffered one of the most brutal drawdowns on the ASX, plunging 42.89% in July alone after an already dismal June. The latest price action leaves Liontown shares with a relative strength index of 20.83, and the tag of the most oversold stock on the ASX, among companies holding a market cap above A$1 billion.

The July collapse caps a devastating two month period for Liontown shareholders. After falling 32.4% in June to A$1.69, the stock has now more than halved from early June highs, cementing its position as the poster child for the broader lithium sector’s reversal.The speed and magnitude of the decline have sparked intense debate about whether the sell-off represents capitulation or a fundamental re-rating of the lithium investment thesis.

The broader ASX lithium cohort has also suffered, though Liontown’s decline stands out for its severity. Pilbara Minerals, Mineral Resources and other lithium-exposed names all struggled in June, although the extent of selling at LTR has been more magnified.

Why Are Liontown Shares Down So Much?

The sell-off reflects a mix of commodity price dynamics, project execution concerns, and legacy valuation anchors.

 

Top Australian Brokers

Spodumene concentrate prices fell approximately 12% in June after a remarkable 196% surge over the preceding twelve months, according to market commentary. More granular data from mid-2026 showed Chinese spodumene prices dropping 18-20% from mid-May to early June, a sharp reversal that directly impacts revenue and margin expectations for Liontown’s flagship Kathleen Valley project in Western Australia.

Kathleen Valley remains the centrepiece of the investment case. The operation is ramping toward a 1.5 million tonnes per annum spodumene concentrate run-rate, with management pushing ahead with early works and long-lead procurement for a planned expansion to 2.8 million tonnes per annum by the June quarter of 2027. A formal final investment decision on the expansion is targeted for the end of the first quarter of fiscal 2027.

Cost pressures remain a persistent worry. Western Australian lithium project capital and operating expenditures are overshooting earlier estimates, with some analysis indicating Liontown’s unit costs may end up only 5-10% below certain higher-cost peers by fiscal 2027 in real terms. Management has acknowledged these pressures and is attempting to lock in long-lead items early to mitigate future cost inflation and scheduling risk. In early July, the company also flagged an expected non-cash impairment of approximately A$40 million on its Lucky Bay asset, reflecting weaker market conditions and revised assumptions on secondary projects.

Technical factors are amplifying the move in both directions. Momentum selling, systematic de-risking and stop-loss flows have kept pressure relentless, but the same dynamics set up the potential for sharp bear-market rallies if a positive catalyst emerges.

The broader lithium sector faces questions about how quickly supply will respond to the recent price spike and whether demand growth from the electric vehicle transition will absorb new capacity without further price corrections.

Liontown’s dramatic collapse from lithium darling to the ASX’s most oversold billion-dollar stock encapsulates the sector’s violent reversal. Holders will be looking for support to step up in August, with the A$1 level the first target.

Bull Case:

  • Kathleen Valley tier-one asset with 2.8Mtpa expansion plan and strong offtakes intact
  • RSI at 20.83 signals extreme oversold; 50%+ drawdown prices in significant downside
  • Positive operating cash flow and funding visibility reduce existential balance-sheet risk

Bear Case:

  • Spodumene prices down 12% in June after 196% run; further correction threatens margins
  • Capex and opex creep into softer price deck creates double-sided execution risk
  • Momentum and systematic selling can keep oversold conditions persistent for extended periods
The Bull Team
The Bull Team is a group of finance writers and journalists that provide commentary and insights on the Australian stock market and beyond.